This is NOT investment advice.
___________________________________________________________________________________________________________________________________________________________
This does not display all Reg CF and/or A+ moves completed. I will publish a report card on that separately. Capital was deployed in the following names during 2024:
- we have published extensive content on AtomBeam, here is the most recent AtomBeam analysis
- quite pleased overall, the company appears to have a good shot and starting to really hit it's stride in terms of commercialization
- we slightly added to our position, the majority of shares obtained at the first and second raise
Cytonics
- Phase I trial underway, no adverse events thus far
- this is a "we're swinging for the fences here" investment
- completely new way to treat osteoarthritis (OA)
- we view this as it either hits big in a very, very big way or is sold off for its IP after years of struggling
Psyonic
- Pretty pleased overall
- revenue is ramping as is the overall growth of the firm
- either it sputters stuck in a niche or takes over the hand market, appears to have a major edge over existing options
- further moves into robotics extra on top
- standing pat
- this one is very new, and you can read all about Hylio as an investment here
